SS Innovations International Beats Global Surgical Robotics Giants to win outstanding company award in surgical robotics technology awards 2026

IMT News Desk
IMT News Desk
· 2 min read
SS Innovations International wins the Outstanding Company award at SRT Industry Awards 2026, marking a major global surgical robotics milestone.

SS Innovations International has been honoured with the Outstanding Company award at the Surgical Robotics Technology (SRT) Industry Awards 2026.

The achievement marks a significant milestone for the company, which was selected from an exceptional field of globally renowned surgical robotics innovators and medical technology leaders, including Intuitive, Medtronic, Johnson & Johnson MedTech, Distalmotion, Meril, MicroPort, THINK Surgical, FUTEK and Precision IO Group, reaffirming its emergence as a leading force in the global surgical robotics landscape.

Now in its fourth edition, the Surgical Robotics Technology (SRT) Industry Awards are regarded as one of the world’s most respected honours, celebrating excellence in surgical robotics. Organised by Surgical Robotics Technology (SRT), the leading global news and intelligence platform dedicated exclusively to the surgical robotics ecosystem, in partnership with QNX, the awards recognise organisations, technologies and industry leaders driving transformative advancements in robotic-assisted surgery. The annual awards celebrate excellence in innovation, clinical impact, technological leadership and commercial achievement across the global surgical robotics landscape.

Commenting on the recognition, Dr. Sudhir Srivastava, Founder Chairman and CEO of SS Innovations International, said, “Winning the Outstanding Company award at the SRT Industry Awards is a proud milestone for SS Innovations International and for India. This recognition validates our commitment to developing world-class surgical robotic technologies that are innovative, accessible and affordable. It inspires us to continue advancing our mission of transforming surgical care through cutting edge technology and expanding access to robotic surgery across the world.”

Over the past few years, SS Innovations International has rapidly established itself as one of the fastest growing innovators in surgical robotics through its flagship SSI Mantra Surgical Robotic System. Developed in India with a vision to democratise robotic surgery, the system has enabled advanced minimally invasive procedures while expanding access to robotic surgery through affordability, technological innovation and pioneering advancements in telesurgery.

The Outstanding Company recognition marks another defining milestone in SS Innovations International’s journey and reinforces India’s growing stature as a global hub for advanced medical technology innovation. It reflects the confidence of the international surgical robotics community in the company’s technological capabilities, vision and commitment to shaping the future of surgery.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk